sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
Cancer pain
1. SYAFRUDDIN GAUS
DEPARTMENT OF ANESTHESIOLOGY, INTENSIVE
CARE AND PAIN MANAGEMENT
FACULTY OF MEDICINE, HASANUDDIN
UNIVERSITY
2. Magnitude of Cancer Pain
Etiology of Cancer Pain
Pathophysiologic of Cancer Pain
Clinical Characteristic of Cancer Pain
Evaluation of Cancer Pain
Management of Cancer Pain
CPD Perioperative IDSAI, Medan Juli 2010
3. Bonica 1985
50 % of patient of all stage reported pain
> 70 % with advanced cancer
Faley 1985
50 % of patient with non metastatic cancer had significant
pain
60-90 % of patient with advanced cancer reported debilitating
pain
WHO 1986
70 % of patient with advanced cancer has pain
3,5 million people suffering from cancer pain with or without
satisfactory treatment every day
Paice, 2006
20-75% have pain at first diagnosis
23- 100% report pain in advance stage
CPD Perioperative IDSAI, Medan Juli 2010
4. TOTAL
PAIN
SOMATIC SOURCE
ANXIETY
ANGERDEPRESSION
Non-cancer pathology
Cancer
Symptoms of debility
Side-effects of theraphy
Loss of social position
Loss of job prestige and income
Loss of role in family
Chronic fatigue and insomnia
Sense of helpessness
Disfigurement
Bureaucratic bungling
Friends who do not visit
Delay in diagnosis
Unavailable doctors
Irritability
Therapeutic failure
Fear of hospital or nursing home
Worry about family
Fear of death
Spiritual unrest
Fear of pain
Family finances
Loss of dignity and bodily control
Uncertainty about future
WHO 1986
CPD Perioperative IDSAI, Medan Juli 2010
5. TUMOR-RELATED PAIN
TREATMENT-RELATED PAIN
DEBILITY-RELATED PAIN
NON-MALIGNANT CONCURRENT DISEASE
CPD Perioperative IDSAI, Medan Juli 2010
8. 1. Nociceptive pain
Somatic pain :
aching, stabbing, throbbing
Well localized
Visceral pain :
obstruction : gnawing, cramping
Organ capsule : aching, sharp, throbbing
Diffuse and difficult localize
May referred to somatic structure
CPD Perioperative IDSAI, Medan Juli 2010
9. 2. Neuropathic pain
Nerve compressions
Burning, prickling, electric like
Area innervated nerve
Malignancy compression
Deafferentation nerve injury
Same nerve compressions + shooting,stabbing
allodynia
Often loss afferent sensory function
Superficial burning pain
CPD Perioperative IDSAI, Medan Juli 2010
10. Sympathetically mediated
Cutaneous vasodilatation, increased skin temperature,
abnormal sweating, tropic cahanges and allodynia
Nondermatomal pattern pain
Diagnostic sympathetic block
3. Psychogenic pain
- after pathology pain generating excluded
- can contribute but pure psychogenic etiology is
rare
CPD Perioperative IDSAI, Medan Juli 2010
11. REFLECT
TUMOR SIZE
LOCATION
EXTENT TISSUE DESTRUCTION
MECHANISM OF PAIN
PAIN INTENSITY USED TO GUIDE ANALGESIC
THERAPY
CPD Perioperative IDSAI, Medan Juli 2010
12. MEDICAL HISTORY
PAIN HISTORY
PAIN ASSESSMENT :
LOCATION
CHARACTER
SEVERITY
ONSET
DURATION
TEMPORAL PATTERN
RELIEVING AND EXACERBATION FACTOR
ASSOCIATED SYMPTOMS
PREVIOUS ANALGESIC THERAPY
SPECIFIC CANCER TREATMENT
CPD Perioperative IDSAI, Medan Juli 2010
13. ORIGINALLY INTRODUCED IN 1986
SIMPLE
THREE STEP
WIDELY AVAILABLE AND INEXPENSIVE ANALGESIC
GLOBALLY DISTRIBUTED AND CURRENTLY
CONSIDERED AS STANDARD FOR MANAGEMENT
CANCER PAIN
CPD Perioperative IDSAI, Medan Juli 2010
15. Mainstay of cancer pain
Multiple routes
Enteral
Parenteral ( iv, sc )
Spinal delivery
Transdermal
Transmucosal
Several formulation :
sustained release eg. MS Contin, Kadian, Avinza.
Rapid release : not available in Indonesia
CPD Perioperative IDSAI, Medan Juli 2010
17. Least lipid soluble
Metabolites M6G and M3G ( longer half lifes )
M6G more potent than morphine
M3G ( no analgesic effect ) role in tolerance
Slow release ( controlled release or sustained
release ) use for chronic and cancer pain
Slow onset, prolonged duration fast
titration its impossible
CPD Perioperative IDSAI, Medan Juli 2010
18. Highly lipid soluble synthetic opioid
Rapid onset and short duration
Metabolite inactive (safe for renal impairment)
Suitable for transdermal administration
CPD Perioperative IDSAI, Medan Juli 2010
19. Synthetized as a potential substitute for
atropine ( atropine like effect )
Weak affinity for NMDA receptor
Pethidine superior in renal and biliary colic
but evidenced show that all opioids are
equally effective
Metabolite is norphetidine ( normeperidine )
with long half-life ( 15-20 hrs )
analgesia ( µ receptors ) but neurotoxicity
( CNS excitation : anxiety, mood changes,
tremors, twitching, myoclonic , convulsion )
CPD Perioperative IDSAI, Medan Juli 2010
20. Treatment
Discontinue pethidine
Substitue to alternative opioid
Symptomatic treatment
DO NOT administer naloxone
Suggest
Dose limit : 1000 mg in first 24 hrs and 600-700
mg/day thereafter, Reduced in elderly
Should be avoided in renal impairment
CPD Perioperative IDSAI, Medan Juli 2010
21. Centrally acting synthetic analgesia
µ receptors activity ( by main metabolite M1
( O-desmethyl-tramadol ))
Inhibit reuptake NE and serotonine (5HT ) in
nerve terminal
Advantages of equianalgesic dose opioid
Less sedation
Less repiratory depression
Less constipation
Nausea and vomiting similar
Not a controlled drug
CPD Perioperative IDSAI, Medan Juli 2010
22. Epilepsy was relatively contra indication
Seizure have been reported but probably
similar with other opioid
Accumulation M1 in renal failure can cause
respiratory depression
Total daily dose : 600 mg
CPD Perioperative IDSAI, Medan Juli 2010
23. Naturally alkaloid like morphine
Metabolized in liver by CYP 2D6
converted to morphine (2-10%)
analgesic effect of Codeine
( ineffective prodrug of morphine )
Usually for mild to moderate pain
Combine with non-opioid agents like
acetominophen or aspirin
increased analgesic efficacy but also
decreased opioid relate adverse effect
CPD Perioperative IDSAI, Medan Juli 2010
25. Analgesic antipyretic
Used in all steps in Stepladder WHO
Recommend dose 4000 mg/d
Dose adjustment in hepatic dysfunction
CPD Perioperative IDSAI, Medan Juli 2010
26. Analgesic, antipyretic and anti-inflammatory
Nonselective agents and selective COX-2
inhibitors
Effective component in multimodal therapy
Carefully selected patients due to adverse
effect
COX-2 inhibitors proveide protection adverse
effect but concern in Cardiovascular effect
CPD Perioperative IDSAI, Medan Juli 2010
27. Antidepressant
Inhibition NE and serotonin reuptake
For neurophatic pain
Delays onset day to week
Mood elevating and sleep enhancing effect
Adverse effect on cardiac , glaucoma n prostatic
Amitriptyline, Nortryptiline and Despiramine
Anticonvulsant
For neurophatic pain eg. Chemotherapy
Na channel blocker : Carbamazepine and clonazepam
Gabapentin : Ca Channel and can act as NMDA
antagonist . 900 – 3600 mg/d
CPD Perioperative IDSAI, Medan Juli 2010
28. Corticosteroids
Inhibit prostaglandin synthesis and reduce
edema
For neuropathic pain syndrome
Bone pain , malignant intestinal obstruction
Dexamethasone 12 – 24 mg once daily
NMDA antagonist
Bind EAA glutamat
For severe neuropathic pain
Routine use limited due to cognitive changes
CPD Perioperative IDSAI, Medan Juli 2010
29. Local anesthetic
Inhibiting ions across neural membrane
Relieving neuropathic pain
Orally, topically, intravenously, subcutaneously,
spinally
For Intractable neuropathic pain :
Lidocaine intravenous 1 – 2 mg/kg ( max 500 mg )
over 1 hour then 1 -2 mg/kg/h continuous infusion
CPD Perioperative IDSAI, Medan Juli 2010
30. Nerve block
Sympathetic nerve block
Myofacial trigger point
Neurolytic block : celiac plexus block
Epidural or intratechal drugs
CPD Perioperative IDSAI, Medan Juli 2010
31. Physical therapy
TENS
Accupuncture
Counterirritation
Psychological approach
Depression and anxiety most often
Cognitive intervention : relaxation
CPD Perioperative IDSAI, Medan Juli 2010